TCT Video: Leon unveils PARTNER trial, speaks to benefits of TAVI

TriMed Staff | September 22, 2010 | Cardiovascular Business | Interventional Cardiology

TCT Video: PARTNER Principal Investigator Martin Leon, MD

WASHINGTON, D.C.—Principal Investigator Martin B. Leon, MD, reviews the outcomes of PARTNER (Placement of AoRTic TraNscathetER Valve Trial), the first U.S. clinical trial to evaluate the safety and effectiveness of the transcatheter aortic valve implantation (TAVI) technique with the Edwards Lifesciences Sapien valve. Results will be presented Thursday, Sept. 22 as a late-breaking clinical trial at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference. Based on the results, Leon recommends its approval for use with patients with aortic stenosis, who are not surgical candidates.

Look more news on the PARTNER trial results in Thursday's TCT Daily Edition from Cardiovascular Business News.

TriMed Staff

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business

Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Related Content

Around the web